Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-12-013875
Filing Date
2012-03-08
Accepted
2012-03-08 21:13:13
Documents
1
Period of Report
2012-03-06

Document Format Files

Seq Description Document Type Size
1 form323010_20120308091233-.html 3  
1 form323010_20120308091233-.xml 3 7570
  Complete submission text file 0001144204-12-013875.txt   10119
Mailing Address 2910 SEVENTH ST BERKLEY CA 94710
Business Address 2910 SEVENTH ST BERKELEY CA 94710 5106441170
XOMA Corp (Issuer) CIK: 0000791908 (see all company filings)

EIN.: 942756657 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address BAKER BROTHERS ADVISORS 667 MADISON AVENUE, 21ST FLOOR NEW YORK NY 10065
Business Address
BAKER JULIAN (Reporting) CIK: 0001087939 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-14710 | Film No.: 12678793

Mailing Address BAKER BROTHERS ADVISORS 667 MADISON AVENUE, 21ST FLOOR NEW YORK NY 10065
Business Address
BAKER FELIX (Reporting) CIK: 0001087940 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-14710 | Film No.: 12678794

Mailing Address 667 MADISON AVENUE 21ST FLOOR NEW YORK NY 10065
Business Address 667 MADISON AVENUE 21ST FLOOR NEW YORK NY 10065 212-339-5600
Baker Brothers Life Sciences Capital (GP), LLC (Reporting) CIK: 0001307729 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 000-14710 | Film No.: 12678795